Pharmacogenomic responses of rat liver to methylprednisolone: An approach to mining a rich microarray time series
暂无分享,去创建一个
Jin Y. Jin | D. DuBois | R. Almon | W. Jusko | William J. Jusko | Richard R. Almon | Debra C. Dubois | Jin Y. Jin
[1] D. DuBois,et al. Pharmacokinetic/Pharmacodynamic models for corticosteroid receptor down-regulation and glutamine synthetase induction in rat skeletal muscle by a Receptor/Gene-mediated mechanism. , 1999, The Journal of pharmacology and experimental therapeutics.
[2] R. Ramakrishnan,et al. Fifth-Generation Model for Corticosteroid Pharmacodynamics: Application to Steady-State Receptor Down-Regulation and Enzyme Induction Patterns During Seven-Day Continuous Infusion of Methylprednisolone in Rats , 2002, Journal of Pharmacokinetics and Pharmacodynamics.
[3] Bialas Mc,et al. Adverse effects of corticosteroids. , 1998 .
[4] D. DuBois,et al. Corticosteroid effects in skeletal muscle: Gene induction/receptor autoregulation , 1997, Muscle & nerve.
[5] N. Friedman,et al. Statistical methods for analyzing gene expression data for cancer research. , 2002, Ernst Schering Research Foundation workshop.
[6] Jin Y. Jin,et al. Modeling of Corticosteroid Pharmacogenomics in Rat Liver Using Gene Microarrays , 2003, Journal of Pharmacology and Experimental Therapeutics.
[7] Frauman Ag,et al. An overview of the adverse reactions to adrenal corticosteroids. , 1996 .
[8] N. Kaminski. Microarray analysis of idiopathic pulmonary fibrosis. , 2003, American journal of respiratory cell and molecular biology.
[9] Richard R. Almon,et al. Fourth-Generation Model for Corticosteroid Pharmacodynamics: A Model for Methylprednisolone Effects on Receptor/Gene-Mediated Glucocorticoid Receptor Down-Regulation and Tyrosine Aminotransferase Induction in Rat Liver , 1998, Journal of Pharmacokinetics and Biopharmaceutics.
[10] A G Frauman,et al. An overview of the adverse reactions to adrenal corticosteroids. , 1996, Adverse drug reactions and toxicological reviews.
[11] M C Bialas,et al. Adverse effects of corticosteroids. , 1998, Adverse drug reactions and toxicological reviews.
[12] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[13] Debra C DuBois,et al. Pharmacodynamics and pharmacogenomics of methylprednisolone during 7-day infusions in rats. , 2002, The Journal of pharmacology and experimental therapeutics.
[14] Jorge R. Oksenberg,et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis , 2002, Nature Medicine.
[15] A. Eisenstein. Effects of adrenal cortical hormones on carbohydrate, protein, and fat metabolism. , 1973, The American journal of clinical nutrition.
[16] Richard R. Almon,et al. Dose-Dependence and Repeated-Dose Studies for Receptor/Gene-Mediated Pharmacodynamics of Methylprednisolone on Glucocorticoid Receptor Down-Regulation and Tyrosine Aminotransferase Induction in Rat Liver , 1998, Journal of Pharmacokinetics and Biopharmaceutics.
[17] Eric P Hoffman,et al. In vivo multi-tissue corticosteroid microarray time series available online at Public Expression Profile Resource (PEPR). , 2003, Pharmacogenomics.
[18] B. Walker,et al. Human insulin resistance: the role of glucocorticoids , 2003, Diabetes, obesity & metabolism.
[19] Shuzhong Zhang,et al. Pharmacodynamics and Pharmacogenomics of Diverse Receptor-Mediated Effects of Methylprednisolone in Rats Using Microarray Analysis , 2002, Journal of Pharmacokinetics and Pharmacodynamics.
[20] J. Enghild,et al. Idiopathic Pulmonary Fibrosis , 2003 .
[21] M. Takiguchi,et al. Transcriptional regulation of genes for ornithine cycle enzymes. , 1995, The Biochemical journal.